Bioactive glass-based core-shell nanoparticles: Multifunctional platforms for controlled drug release and biomedical applications

  • 0Institute of Biomaterials, University of Erlangen-Nuremberg, 91058, Erlangen, Germany.

|

|

Summary

This summary is machine-generated.

Core-shell nanoparticles with bioactive glass cores offer advanced biomedical applications. These engineered nanomaterials provide tunable drug release and enhanced biological performance for next-generation therapies.

Area Of Science

  • Biomaterials Science
  • Nanotechnology
  • Materials Chemistry

Background

  • Core-shell nanoparticles are multifunctional platforms for precise control in biomedical applications.
  • Bioactive glasses offer advantages over silica due to bioactivity and therapeutic ion release.

Purpose Of The Study

  • To comprehensively review core-shell nanostructures with bioactive glass cores.
  • To analyze shell materials for controlled release and biological performance.

Main Methods

  • Discussed composition and synthesis of bioactive glass nanoparticles.
  • Evaluated inorganic and polymeric shell materials for physicochemical roles.
  • Explored challenges and future directions for clinical implementation.

Main Results

  • Shell materials modulate drug diffusion, stability, degradation, and targeting.
  • Bioactive glass core-shell structures offer tunable properties for tailored therapies.
  • Inorganic, natural, and synthetic polymeric shells provide versatile engineering options.

Conclusions

  • Core-shell bioactive glass nanoparticles represent a customizable strategy for advanced biomedical therapies.
  • Surface engineering integrates structural functionalities for next-generation treatments.
  • Addressing challenges in in vivo assays and clinical translation is crucial for implementation.

Related Concept Videos

Drug Delivery: Overview 01:16

718

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...

Bioavailability Enhancement: Drug Permeability Enhancement 01:27

183

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...

<i>In Vitro</i> Drug Release Testing: Overview, Development and Validation 01:10

302

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention 01:05

193

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...